M M A Tilanus-Linthorst

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
    Sepideh Saadatmand
    Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands
    BMC Cancer 12:440. 2012
  2. doi request reprint Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 133:156-63. 2013
  3. pmc Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
    Murly Bm Tan
    Department of Psychosocial Care, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Hered Cancer Clin Pract 7:6. 2009
  4. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  5. ncbi request reprint BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials
    Madeleine M A Tilanus-Linthorst
    Department of Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Cancer Res 13:7357-62. 2007
  6. ncbi request reprint Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Breast Cancer Res Treat 95:117-23. 2006
  7. ncbi request reprint Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer
    M M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Surg 93:961-8. 2006
  8. doi request reprint Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis
    B A M Heemskerk-Gerritsen
    Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 24:2029-35. 2013
  9. ncbi request reprint Survival and prognostic factors in BRCA1-associated breast cancer
    C T M Brekelmans
    Department of Medical Oncology, Department of Surgical Oncology and Department of Clinical Genetics, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 17:391-400. 2006
  10. ncbi request reprint Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
    M Kriege
    Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Centre, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:357-63. 2007

Collaborators

Detail Information

Publications18

  1. pmc Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
    Sepideh Saadatmand
    Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands
    BMC Cancer 12:440. 2012
    ..The aim of the Familial MRI Screening Study (FaMRIsc) is to compare the efficacy of MRI screening to mammography for women with a familial risk. Furthermore, we will assess the influence of breast density...
  2. doi request reprint Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 133:156-63. 2013
    ..Age at breast cancer diagnosis is partly dependent on family history which may assist planning starting age for preventive measures...
  3. pmc Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
    Murly Bm Tan
    Department of Psychosocial Care, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Hered Cancer Clin Pract 7:6. 2009
    ..This may help them arrive at an informed decision, to detect and manage psychological distress, and to plan psychological support services...
  4. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  5. ncbi request reprint BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials
    Madeleine M A Tilanus-Linthorst
    Department of Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Cancer Res 13:7357-62. 2007
    ..We investigated the effect of a BRCA1 or BRCA2 mutation and age on the growth rate of breast cancers, as this may influence the optimal screening frequency...
  6. ncbi request reprint Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Breast Cancer Res Treat 95:117-23. 2006
    ..A higher incidence of contralateral breast cancer (CBC) has been reported in familial BC. Ascertainment bias may influence both the reported familial CBC and survival...
  7. ncbi request reprint Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer
    M M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Br J Surg 93:961-8. 2006
    ..This study investigated the influence of contralateral cancer and tumour stage on survival in patients with familial non-BRCA1/BRCA2-associated breast cancer...
  8. doi request reprint Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis
    B A M Heemskerk-Gerritsen
    Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 24:2029-35. 2013
    ..To prospectively assess the efficacy of bilateral risk-reducing mastectomy (BRRM) when compared with surveillance on breast cancer (BC) risk and mortality in healthy BRCA1 and BRCA2 mutation carriers...
  9. ncbi request reprint Survival and prognostic factors in BRCA1-associated breast cancer
    C T M Brekelmans
    Department of Medical Oncology, Department of Surgical Oncology and Department of Clinical Genetics, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 17:391-400. 2006
    ..Further, the prognostic impact of the classical tumour and treatment factors is unclear in BRCA1-associated BC...
  10. ncbi request reprint Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
    M Kriege
    Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Centre, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:357-63. 2007
    ....
  11. doi request reprint Breast cancer screening: evidence for false reassurance?
    Rianne De Gelder
    Department of Public Health, Erasmus MC, 3000 CA Rotterdam, The Netherlands
    Int J Cancer 123:680-6. 2008
    ..0 days (95% C.I. 5.9-8.1) in symptomatic screened patients and 6.0 days (95% C.I. 4.0-8.0) in control patients. Our results show that false reassurance played, at most, only a minor role in breast cancer screening...
  12. ncbi request reprint Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients
    Mieke Kriege
    Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast Cancer Res Treat 111:303-11. 2008
    ..Data on distant disease-free interval (DDFI) and the localization of the first distant metastasis (DM) in BRCA1- and BRCA2-associated breast cancer (BC) patients are as yet scarcely available...
  13. pmc Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic
    Bernadette A M Heemskerk-Gerritsen
    Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Surg Oncol 14:3335-44. 2007
    ..Prophylactic mastectomy (PM) results in the greatest BC risk reduction. Long-term data on the efficacy and sequels of PM are scarce...
  14. ncbi request reprint Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer
    Mieke Kriege
    Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Breast Cancer Res Treat 100:109-19. 2006
    ..In the current subsequent study we investigated whether these results are influenced by age, a BRCA1/2 mutation, menopausal status and breast density...
  15. ncbi request reprint Hereditary breast cancer growth rates and its impact on screening policy
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur J Cancer 41:1610-7. 2005
    ..It is recommended that the screening frequency should be adjusted according to a woman's age and a high-sensitive biannual test may be appropriate before the age of 40 years...
  16. ncbi request reprint Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer
    Silvia van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 41:1416-25. 2005
    ..The course of general distress differed significantly for women closely involved in a sister's BC-process. These more vulnerable subgroups may be in need of extra counselling and care...
  17. ncbi request reprint Psychological distress in women at increased risk for breast cancer: the role of risk perception
    Silvia van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 40:2056-63. 2004
    ..This knowledge should be used during surveillance appointments in order to improve and individualise support for these women...
  18. ncbi request reprint Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
    Mieke Kriege
    Rotterdam Family Cancer Clinic, Department of Medical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    N Engl J Med 351:427-37. 2004
    ..We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women...